Martingale Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.8K | Sell |
|
|||||
|
2025
Q1 | $105K | Sell |
|
|||||
|
2024
Q4 | $310K | Sell |
|
|||||
|
2024
Q3 | $328K | Sell |
|
|||||
|
2024
Q2 | $427K | Hold |
|
|||||
|
2024
Q1 | $310K | Buy |
|
|||||
|
2023
Q4 | $306K | Sell |
|
|||||
|
2023
Q3 | $347K | Buy |
|
|||||
|
2023
Q2 | $441K | Buy |
|
|||||
|
2023
Q1 | $330K | Sell |
|
|||||
|
2022
Q4 | $585K | Buy |
|
|||||
|
2022
Q3 | $758K | Buy |
|
|||||
|
2022
Q2 | $268K | Sell |
|
|||||
|
2022
Q1 | $339K | Sell |
|
|||||
|
2021
Q4 | $1.2M | Sell |
|
|||||
|
2021
Q3 | $1.37M | Buy |
|
|||||
|
2021
Q2 | $1.43M | Sell |
|
|||||
|
2021
Q1 | $1.02M | Buy |
|
|||||
|
2020
Q4 | $818K | Buy |
|
|||||
|
2020
Q3 | $532K | Sell |
|
|||||
|
2020
Q2 | $1.14M | Buy |
|